Sanjeev Narula

Companies

• Phathom Pharmaceuticals, Inc.Chief financial officer Oct 7, 2025 to now¹
• Intra-Cellular Therapies, Inc.Chief financial officer Aug 14, 2024 to Apr 2, 2025²
• ViatrisChief financial officer Aug 6, 2020 to Mar 6, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPPhathom Pharmaceuticals, Inc. PHAT226,715 shares⁴$1.6M at $7.03Jan 2, 2026
• Viatris VTRS73,877 shares⁵$1.4M at $18.64Mar 4, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 2, 2026Granted 82,715 shares of Phathom Pharmaceuticals, Inc.⁴
• Oct 6, 2025Granted 144,000 shares of Phathom Pharmaceuticals, Inc.⁶
• Mar 4, 2023Shares withheld for tax 608 shares at $11.13 of Viatris⁵
• Mar 4, 2023Exercised options 1,398 shares of Viatris⁵
• Mar 4, 2023Shares withheld for tax 16,909 shares at $11.13 of Viatris⁵
• Mar 4, 2023Exercised options 38,889 shares of Viatris⁵
• Mar 2, 2023Shares withheld for tax 899 shares at $11.13 of Viatris⁵
• Mar 2, 2023Exercised options 2,067 shares of Viatris⁵
• Mar 2, 2023Shares withheld for tax 11,360 shares at $11.13 of Viatris⁵
• Mar 2, 2023Exercised options 26,125 shares of Viatris⁵
• Feb 27, 2023Shares withheld for tax 674 shares at $11.20 of Viatris⁷
• Feb 27, 2023Exercised options 1,550 shares of Viatris⁷
• Feb 27, 2023Shares withheld for tax 9,326 shares at $11.20 of Viatris⁷
• Feb 27, 2023Exercised options 21,246 shares of Viatris⁷
• Mar 2, 2022Shares withheld for tax 272 shares at $10.48 of Viatris⁸
• Mar 2, 2022Exercised options 625 shares of Viatris⁸
• Mar 2, 2022Shares withheld for tax 11,415 shares at $10.48 of Viatris⁸
• Mar 2, 2022Exercised options 26,126 shares of Viatris⁸